HomeHOWL • NASDAQ
add
Werewolf Therapeutics Inc
Previous close
$1.57
Day range
$1.59 - $1.83
Year range
$0.60 - $3.26
Market cap
80.94M USD
Avg Volume
1.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.57M | -10.86% |
Net income | -17.98M | -4.25% |
Net profit margin | — | — |
Earnings per share | -0.40 | -4.28% |
EBITDA | -17.14M | 7.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 77.60M | -42.65% |
Total assets | 92.57M | -39.78% |
Total liabilities | 51.10M | 2.85% |
Total equity | 41.46M | — |
Shares outstanding | 45.73M | — |
Price to book | 1.73 | — |
Return on assets | -43.90% | — |
Return on capital | -50.72% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -17.98M | -4.25% |
Cash from operations | -15.16M | -6.96% |
Cash from investing | — | — |
Cash from financing | 388.00K | 103.99% |
Net change in cash | -14.78M | 38.21% |
Free cash flow | -8.95M | -11.02% |
About
Founded
2017
Headquarters
Website
Employees
46
